Insider Transactions last 24 months for MBX Biosciences, Inc.  -  NSDQ: MBX

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Hawryluk P. KentPresident & CEO03/13/2026APIndirectCOM18,500$28.41$525,662.70486,777
Hawryluk P. KentPresident & CEO02/26/2026AMDirectCOM28,768$16.00$460,288.00728,274
Hawryluk P. KentPresident & CEO02/02/2026AADirectCOM35,250$0.00$0.00699,506
Bartram RichardChief Financial Officer02/02/2026AADirectCOM15,000$0.00$0.0015,000
Azoulay SalomonChief Medical Officer02/02/2026AADirectCOM15,000$0.00$0.0015,000
Hawryluk P. KentPresident & CEO10/24/2025AMDirectCOM182,859$3.25$594,291.75664,256
Hawryluk P. KentPresident & CEO10/20/2025APIndirectCOM20,000$13.64$272,790.00468,277
Hoerter Steven L.Director10/17/2025APIndirectCOM20,000$13.25$264,984.0020,000
Heron Patrick JDirector09/26/2025APIndirectCOM666,666$18.00$11,999,988.005,219,440
Pescovitz Ora H.Director04/08/2025APDirectCOM7,693$5.89$45,311.7724,329
Orbimed Advisors LlcDirector02/18/2025APIndirectCOM94,100$10.84$1,020,044.00747,887
Orbimed Advisors LlcDirector02/18/2025APIndirectCOM49,070$10.84$531,918.803,255,000
Gordon Carl LDirector02/18/2025APIndirectCOM94,100$10.84$1,020,044.00747,887
Gordon Carl LDirector02/18/2025APIndirectCOM49,070$10.84$531,918.803,255,000
Orbimed Advisors LlcDirector02/14/2025APIndirectCOM29,540$9.85$290,969.003,205,930
Orbimed Advisors LlcDirector02/14/2025APIndirectCOM17,962$9.90$177,823.803,176,390
Gordon Carl LDirector02/14/2025APIndirectCOM29,540$9.85$290,969.003,205,930
Gordon Carl LDirector02/14/2025APIndirectCOM17,962$9.90$177,823.803,176,390
Hawryluk P. KentPresident & CEO02/04/2025APIndirectCOM50,000$10.69$534,500.00448,277
Wellington Biomedical Innovation Master Investors (Cayman) Ii L.P.Other09/16/2024ACDirectCOM403,787$0.00$0.001,790,122
Wellington Biomedical Innovation Master Investors (Cayman) Ii L.P.Other09/16/2024ACDirectCOM1,386,335$0.00$0.001,386,335
Gordon Carl LDirector09/16/2024APIndirectCOM250,000$16.00$4,000,000.00653,787
Gordon Carl LDirector09/16/2024APIndirectCOM500,000$16.00$8,000,000.003,158,428
Gordon Carl LDirector09/16/2024ACIndirectCOM403,787$0.00$0.00403,787
Gordon Carl LDirector09/16/2024ACIndirectCOM2,658,428$0.00$0.002,658,428
1   2  3  Next Last  You are at page 1 of 3 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel